Sunscreen TEA Advocates Want Help Scaling FDA’s ‘High Bar’ For OTC Monographs
This article was originally published in The Tan Sheet
Executive Summary
FDA explains its “high bar” for GRASE for sunscreen TEAs during a public meeting on implementation of the Sunscreen Innovation Act. Industry and advocacy groups express concern that impediments to meeting OTC monograph safety standards will squelch sunscreen ingredient innovation.
You may also be interested in...
All Roads For OTC Policy Improvements Lead To User Fees, FDA Suggests
During update on user fee discussions with industry to support FDA's OTC monograph program work, CDER officials say "industry and public would suffer" absent new fees.
All Roads For OTC Policy Improvements Lead To User Fees, FDA Suggests
During update on user fee discussions with industry to support FDA's OTC monograph program work, CDER officials say "industry and public would suffer" absent new fees.
Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking
The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.